Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):589–597. doi: 10.1097/QAI.0000000000001147

Table 2.

Description of hospitalisations for anxiety and mood disorders in HIV-infected and –uninfected gay and bisexual men, 2000–2012

HIV-uninfected Cohort HIV-infected Cohort P-value for Cohort Comparison
Number of participants 1325 557
Total Follow-up Time, years 13025 5580
Crude Rate of Hospital Admissions for Mood and/or Anxiety-disorders, per 100 Pys (95% CI) 1.4 (1.2–1.6) 5.4 (4.8–6.0) <0.001
Number of Hospital Admission for a Mood and/or Anxiety-disorder 181 300
 Number of Mood Hospitalisations, N (%)     131 (72.4)     228 (76.0)
 Number of Anxiety Hospitalisations, N (%)     34 (18.8)     56 (18.7)
 Number of Both Mood and Anxiety Hospitalisations, N (%)     16 (8.8)     16 (5.3)
Number of Participants with a Hospital Admission for Mood and/or Anxiety-disorder 72 (5.4) 85 (15.3) <0.001
Number of participants with a readmission, N (%) 29 (40.3) 40 (55.3) 0.061
Crude Rate of Hospital Admissions for a Mood and/or Anxiety-disorder resulting in transfer to a Psychiatric Ward, N (%) 0.5 (0.4–0.6) 1.4 (1.1–1.7) 0.011
Median Length of Stay per AMDs admission, days (IQR) 2.0 (1.0–7.0)× 5.0 (2.0–12.0) <0.001
Median Length of Stay per other (non-AMDs) admission, days (IQR) 1.0 (1.0–2.0)× 2.0 (1.0–5.0) <0.001
General population comparison:
 Standardized Incidence Ratio (95%CI) 3.33 (2.20–5.03) 9.73 (5.35–17.67)

General population comparison only for primary diagnoses, adjusted for age and year of diagnosis

×

p-value for comparison <0.0001

p-value for comparison <0.0001